150 related articles for article (PubMed ID: 22690875)
1. Clinically relevant hypoglycemia prediction metrics for event mitigation.
Harvey RA; Dassau E; Zisser HC; Bevier W; Seborg DE; Jovanovič L; Doyle FJ
Diabetes Technol Ther; 2012 Aug; 14(8):719-27. PubMed ID: 22690875
[TBL] [Abstract][Full Text] [Related]
2. The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise.
Danne T; Tsioli C; Kordonouri O; Blaesig S; Remus K; Roy A; Keenan B; Lee SW; Kaufman FR
Diabetes Technol Ther; 2014 Jun; 16(6):338-47. PubMed ID: 24447074
[TBL] [Abstract][Full Text] [Related]
3. Detection of hypoglycemia associated EEG changes during sleep in type 1 diabetes mellitus.
Snogdal LS; Folkestad L; Elsborg R; Remvig LS; Beck-Nielsen H; Thorsteinsson B; Jennum P; Gjerstad M; Juhl CB
Diabetes Res Clin Pract; 2012 Oct; 98(1):91-7. PubMed ID: 22809714
[TBL] [Abstract][Full Text] [Related]
4. Effect of short-term use of a continuous glucose monitoring system with a real-time glucose display and a low glucose alarm on incidence and duration of hypoglycemia in a home setting in type 1 diabetes mellitus.
Davey RJ; Jones TW; Fournier PA
J Diabetes Sci Technol; 2010 Nov; 4(6):1457-64. PubMed ID: 21129341
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
Nicolucci A; Rossi MC; D'Ostilio D; Delbaere A; de Portu S; Roze S
Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):707-715. PubMed ID: 29753586
[TBL] [Abstract][Full Text] [Related]
6. An integrated multivariable artificial pancreas control system.
Turksoy K; Quinn LT; Littlejohn E; Cinar A
J Diabetes Sci Technol; 2014 May; 8(3):498-507. PubMed ID: 24876613
[TBL] [Abstract][Full Text] [Related]
7. Hypoglycemic Accuracy and Improved Low Glucose Alerts of the Latest Dexcom G4 Platinum Continuous Glucose Monitoring System.
Peyser TA; Nakamura K; Price D; Bohnett LC; Hirsch IB; Balo A
Diabetes Technol Ther; 2015 Aug; 17(8):548-54. PubMed ID: 25961446
[TBL] [Abstract][Full Text] [Related]
8. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
[TBL] [Abstract][Full Text] [Related]
9. Hypoglycemia prevention via pump attenuation and red-yellow-green "traffic" lights using continuous glucose monitoring and insulin pump data.
Hughes CS; Patek SD; Breton MD; Kovatchev BP
J Diabetes Sci Technol; 2010 Sep; 4(5):1146-55. PubMed ID: 20920434
[TBL] [Abstract][Full Text] [Related]
10. A 5-Step Approach Protocol Using CareLink Therapy Software in Type 1 Diabetes Patients.
Petrovski G; Zivkovic M
J Diabetes Sci Technol; 2017 Nov; 11(6):1277. PubMed ID: 28879783
[No Abstract] [Full Text] [Related]
11. Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension.
Buckingham B; Chase HP; Dassau E; Cobry E; Clinton P; Gage V; Caswell K; Wilkinson J; Cameron F; Lee H; Bequette BW; Doyle FJ
Diabetes Care; 2010 May; 33(5):1013-7. PubMed ID: 20200307
[TBL] [Abstract][Full Text] [Related]
12. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
[TBL] [Abstract][Full Text] [Related]
13. Clinical Impact of Blood Glucose Monitoring Accuracy: An In-Silico Study.
Campos-Náñez E; Fortwaengler K; Breton MD
J Diabetes Sci Technol; 2017 Nov; 11(6):1187-1195. PubMed ID: 28569076
[TBL] [Abstract][Full Text] [Related]
14. Automatic data processing to achieve a safe telemedical artificial pancreas.
Hernando ME; García-Sáez G; Martínez-Sarriegui I; Rodríguez-Herrero A; Pérez-Gandía C; Rigla M; de Leiva A; Capel I; Pons B; Gómez EJ
J Diabetes Sci Technol; 2009 Sep; 3(5):1039-46. PubMed ID: 20144417
[TBL] [Abstract][Full Text] [Related]
15. Analysis: high-tech diabetes technology and the myth of clinical "plug and play".
Weinzimer SA
J Diabetes Sci Technol; 2010 Nov; 4(6):1465-7. PubMed ID: 21129342
[TBL] [Abstract][Full Text] [Related]
16. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
Diabetes Care; 2010 May; 33(5):1004-8. PubMed ID: 20200306
[TBL] [Abstract][Full Text] [Related]
17. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.
Garg S; Brazg RL; Bailey TS; Buckingham BA; Slover RH; Klonoff DC; Shin J; Welsh JB; Kaufman FR
Diabetes Technol Ther; 2012 Mar; 14(3):205-9. PubMed ID: 22316089
[TBL] [Abstract][Full Text] [Related]
18. Glycemic Tracking Before and After Insulin Pump Initiation.
Johnson A; Hill NE; Godsland I; Oliver NS
J Diabetes Sci Technol; 2020 Sep; 14(5):970-971. PubMed ID: 32146846
[No Abstract] [Full Text] [Related]
19. The university of Virginia/Padova type 1 diabetes simulator matches the glucose traces of a clinical trial.
Visentin R; Dalla Man C; Kovatchev B; Cobelli C
Diabetes Technol Ther; 2014 Jul; 16(7):428-34. PubMed ID: 24571584
[TBL] [Abstract][Full Text] [Related]
20. Glucose variability indices in type 1 diabetes: parsimonious set of indices revealed by sparse principal component analysis.
Fabris C; Facchinetti A; Sparacino G; Zanon M; Guerra S; Maran A; Cobelli C
Diabetes Technol Ther; 2014 Oct; 16(10):644-52. PubMed ID: 24956070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
